{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:44:42Z","timestamp":1768898682347,"version":"3.49.0"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003973","name":"Israel Academy of Sciences and Humanities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.phrs.2020.105340","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T20:06:25Z","timestamp":1606853185000},"page":"105340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders"],"prefix":"10.1016","volume":"164","author":[{"given":"Gregory","family":"Livshits","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kalinkovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunology"},{"issue":"June","key":"10.1016\/j.phrs.2020.105340_bib0010","article-title":"Specialized pro-resolving lipid mediators: emerging therapeutic candidates for multiple sclerosis","volume":"2020","author":"Zahoor","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.joca.2017.10.013","article-title":"Hierarchical, imbalanced pro-inflammatory cytokine networks govern the pathogenesis of chronic arthropathies","volume":"26","author":"Livshits","year":"2018","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0020","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/s41467-018-05800-6","article-title":"Resolution of chronic inflammatory disease: universal and tissue-specific concepts","volume":"9","author":"Schett","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2020.105340_bib0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.arr.2016.09.008","article-title":"Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis","volume":"35","author":"Kalinkovich","year":"2017","journal-title":"Ageing Res. Rev."},{"issue":"9","key":"10.1016\/j.phrs.2020.105340_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phrs.2020.105340_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100980","article-title":"Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis","volume":"56","author":"Livshits","year":"2019","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12931-017-0640-8","article-title":"Regulation of human airway smooth muscle cell migration and relevance to asthma","volume":"18","author":"Salter","year":"2017","journal-title":"Respir. Res."},{"issue":"10122","key":"10.1016\/j.phrs.2020.105340_bib0045","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","article-title":"Asthma","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2020.105340_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101346","article-title":"Immune induction of airway remodeling","volume":"46","author":"Guida","year":"2019","journal-title":"Semin. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2020.105340_bib0055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/cvr\/cvy004","article-title":"Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension","volume":"114","author":"Stenmark","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2020.105340_bib0060","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.2147\/COPD.S176122","article-title":"Role of inflammatory cells in airway remodeling in COPD","volume":"13","author":"Wang","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.phrs.2020.105340_bib0065","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3389\/fphar.2018.01488","article-title":"Specialized pro-resolving lipid mediators: modulation of diabetes-associated cardio-, Reno-, and retino-vascular complications","volume":"9","author":"de Gaetano","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.phrs.2020.105340_bib0070","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.3390\/ijms20225694","article-title":"The role of vascular smooth muscle cells in arterial remodeling: focus on calcification-related processes","volume":"20","author":"Jaminon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.105340_bib0075","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3389\/fimmu.2019.01101","article-title":"Vascular smooth muscle cells contribute to atherosclerosis immunity","volume":"10","author":"Hu","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2020.105340_bib0080","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"July (20)","key":"10.1016\/j.phrs.2020.105340_bib0085","first-page":"30095","article-title":"Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy","author":"Kim","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.phrs.2020.105340_bib0090","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/ATVBAHA.118.311229","article-title":"Vascular smooth muscle remodeling in conductive and resistance arteries in hypertension","volume":"38","author":"Brown","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2020.105340_bib0095","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1274034","article-title":"Cardiovascular disease in ageing: an overview on thoracic aortic aneurysm as an emerging inflammatory disease","volume":"2017","author":"Pisano","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1540\/jsmr.43.43","article-title":"Mechanism of abnormal intestinal motility in inflammatory bowel disease: how smooth muscle contraction is reduced?","volume":"43","author":"Ohama","year":"2007","journal-title":"J. Smooth Muscle Res."},{"issue":"5","key":"10.1016\/j.phrs.2020.105340_bib0105","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/j.gastro.2019.12.034","article-title":"Mechanisms, evaluation, and management of chronic constipation","volume":"158","author":"Bharucha","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/pr.115.010652","article-title":"Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders","volume":"68","author":"Brozovich","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2020.105340_bib0115","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1161\/ATVBAHA.119.312581","article-title":"Smooth muscle cells in vascular remodeling","volume":"39","author":"Shi","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2020.105340_bib0120","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/ATVBAHA.119.312131","article-title":"Smooth muscle cell phenotypic diversity","volume":"39","author":"Liu","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2020.105340_bib0125","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.201601222R","article-title":"Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms","volume":"31","author":"Serhan","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2020.105340_bib0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mam.2017.03.005","article-title":"Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors","volume":"58","author":"Chiang","year":"2017","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.phrs.2020.105340_bib0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mam.2017.02.003","article-title":"Specialized pro-resolving mediators in cardiovascular diseases","volume":"58","author":"Fredman","year":"2017","journal-title":"Mol. Aspects Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.105340_bib0140","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1152\/physrev.00026.2017","article-title":"Specialized proresolving mediators in innate and adaptive immune responses in airway diseases","volume":"98","author":"Krishnamoorthy","year":"2018","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.phrs.2020.105340_bib0145","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phrs.2020.105340_bib0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/1570159X17666191019170244","article-title":"The contribution of formyl peptide receptor dysfunction to the course of neuroinflammation: a potential role in the brain pathology","volume":"18","author":"Trojan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"15","key":"10.1016\/j.phrs.2020.105340_bib0155","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1073\/pnas.1617290114","article-title":"Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection","volume":"114","author":"Gobbetti","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.phrs.2020.105340_bib0160","doi-asserted-by":"crossref","first-page":"L904","DOI":"10.1152\/ajplung.00370.2014","article-title":"Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent","volume":"308","author":"Orr","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2020.105340_bib0165","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/ijms21041384","article-title":"The novel small-molecule Annexin-A1 mimetic, compound 17b, elicits vasoprotective actions in streptozotocin-induced diabetic mice","volume":"21","author":"Marshall","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0170","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/cea.12675","article-title":"Mast cells in asthma--state of the art","volume":"46","author":"Bradding","year":"2016","journal-title":"Clin. Exp. Allergy"},{"issue":"7","key":"10.1016\/j.phrs.2020.105340_bib0175","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/14712598.2018.1492540","article-title":"Biological therapies for eosinophilic asthma","volume":"18","author":"Patel","year":"2018","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.phrs.2020.105340_bib0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2018.05.006","article-title":"Role of neutrophils in allergic asthma","volume":"54","author":"Radermecker","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.phrs.2020.105340_bib0185","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3389\/fimmu.2019.00861","article-title":"Innate lymphoid cells in mucosal immunity","volume":"10","author":"Panda","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0190","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1753425918821732","article-title":"Regulation of lung immunity by dendritic cells: implications for asthma, chronic obstructive pulmonary disease and infectious disease","volume":"25","author":"Peters","year":"2019","journal-title":"Innate Immun."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1513\/pats.200705-063VS","article-title":"Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration","volume":"5","author":"Bentley","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0200","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-065X.2011.01022.x","article-title":"Airway smooth muscle and immunomodulation in acute exacerbations of airway disease","volume":"242","author":"Koziol-White","year":"2011","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2020.105340_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081494","article-title":"Bronchial smooth muscle cells of asthmatics promote angiogenesis through elevated secretion of CXC-chemokines (ENA-78, GRO-\u03b1, and IL-8)","volume":"8","author":"Keglowich","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.phrs.2020.105340_bib0210","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1152\/japplphysiol.00950.2012","article-title":"Airway smooth muscle in the pathophysiology and treatment of asthma","volume":"114","author":"Doeing","year":"2013","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0215","doi-asserted-by":"crossref","first-page":"L1113","DOI":"10.1152\/ajplung.00370.2016","article-title":"Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease","volume":"311","author":"Prakash","year":"2016","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.phrs.2020.105340_bib0220","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.abb.2019.01.002","article-title":"Mitochondrial regulation of airway smooth muscle functions in health and pulmonary diseases","volume":"663","author":"Pan","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pupt.2012.08.005","article-title":"Phenotype modulation of airway smooth muscle in asthma","volume":"26","author":"Wright","year":"2013","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2020.105340_bib0230","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.chest.2017.03.020","article-title":"Mitochondrial dysfunction in airway disease","volume":"152","author":"Prakash","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0235","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MCP.0000000000000441","article-title":"Airway remodeling in asthma: update on mechanisms and therapeutic approaches","volume":"24","author":"Boulet","year":"2018","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.105340_bib0240","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/ijms21030757","article-title":"Immunologic and non-immunologic mechanisms leading to airway remodeling in asthma","volume":"21","author":"Fang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2020.105340_bib0245","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1152\/physrev.00003.2017","article-title":"Vascular smooth muscle cells and arterial stiffening: relevance in development, aging, and disease","volume":"97","author":"Lacolley","year":"2017","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0250","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1161\/ATVBAHA.117.309578","article-title":"Aortic aneurysms","volume":"37","author":"Lu","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0255","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2020.105340_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases","volume":"100","author":"Incalza","year":"2018","journal-title":"Vascul. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2020.105340_bib0265","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1248\/bpb.b19-00531","article-title":"Organ\/Tissue-specific vascular endothelial cell heterogeneity in health and disease","volume":"42","author":"Minami","year":"2019","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apha.12466","article-title":"Vascular smooth muscle cell in atherosclerosis","volume":"214","author":"Chistiakov","year":"2015","journal-title":"Acta Physiol. (Oxf.)"},{"issue":"4","key":"10.1016\/j.phrs.2020.105340_bib0275","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2020.105340_bib0280","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3389\/fphar.2019.01276","article-title":"Immune and smooth muscle cells interactions in atherosclerosis: how to target a breaking bad dialogue?","volume":"10","author":"Ramel","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0285","first-page":"306","article-title":"The aorta can act as a site of na\u00efve CD4+ T-cell priming","volume":"116","author":"MacRitchie","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.phrs.2020.105340_bib0290","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/ATVBAHA.120.312464","article-title":"Perivascular adipose tissue regulates vascular function by targeting vascular smooth muscle cells","volume":"40","author":"Chang","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20110151","article-title":"Perivascular adipose tissue: more than just structural support","volume":"122","author":"Szasz","year":"2012","journal-title":"Clin. Sci."},{"issue":"20","key":"10.1016\/j.phrs.2020.105340_bib0300","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1111\/bph.13705","article-title":"Perivascular adipose tissue inflammation in vascular disease","volume":"174","author":"Nosalski","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2020.105340_bib0305","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cellsig.2018.08.019","article-title":"Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity","volume":"52","author":"Frismantiene","year":"2018","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.phrs.2020.105340_bib0310","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/cvr\/cvy022","article-title":"Smooth muscle cell fate and plasticity in atherosclerosis","volume":"114","author":"Allahverdian","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.phrs.2020.105340_bib0315","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0320","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13762","article-title":"Functional Constipation Guidelines Working Group. European society of neurogastroenterology and motility guidelines on functional constipation in adults","volume":"32","author":"Serra","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0325","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MCG.0000000000001047","article-title":"Pathophysiology, diagnosis, and management of chronic intestinal pseudo-obstruction","volume":"52","author":"Downes","year":"2018","journal-title":"J. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.phrs.2020.105340_bib0330","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00384-017-2960-z","article-title":"Systematic review and comparison of national and international guidelines on diverticular disease","volume":"33","author":"Galetin","year":"2018","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.phrs.2020.105340_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/164_2016_118","article-title":"Gastrointestinal physiology and function","volume":"239","author":"Greenwood-Van Meerveld","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0340","doi-asserted-by":"crossref","first-page":"G853","DOI":"10.1152\/ajpgi.00206.2019","article-title":"Enteric neuroplasticity and dysmotility in inflammatory disease: key players and possible therapeutic targets","volume":"317","author":"Spear","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"12","key":"10.1016\/j.phrs.2020.105340_bib0345","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13406","article-title":"Neuronal regulation of intestinal immune functions in health and disease","volume":"30","author":"Fornai","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.phrs.2020.105340_bib0350","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-physiol-021317-121515","article-title":"Unexpected roles for the second brain: enteric nervous system as master regulator of bowel function","volume":"81","author":"Schneider","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phrs.2020.105340_bib0355","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.conb.2019.11.020","article-title":"Intestinal neuro-immune interactions: focus on macrophages, mast cells and innate lymphoid cells","volume":"62","author":"Stakenborg","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"issue":"8","key":"10.1016\/j.phrs.2020.105340_bib0360","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/MIB.0000000000000854","article-title":"Molecular signaling and dysfunction of the human reactive enteric glial cell phenotype: implications for GI infection, IBD, POI, neurological, motility, and GI disorders","volume":"22","author":"Li\u00f1\u00e1n-Rico","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2020.105340_bib0365","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3389\/fphys.2019.01229","article-title":"Dysbiosis-associated enteric glial cell immune-activation and redox imbalance modulate tight junction protein expression in gulf war illness pathology","volume":"10","author":"Kimono","year":"2019","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2020.105340_bib0370","doi-asserted-by":"crossref","first-page":"G367","DOI":"10.1152\/ajpgi.00232.2016","article-title":"Involvement of gut microbiota in association between GLP-1\/GLP-1 receptor expression and gastrointestinal motility","volume":"312","author":"Yang","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2020.105340_bib0375","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.phrs.2018.06.017","article-title":"What is the role of endogenous gut serotonin in the control of gastrointestinal motility?","volume":"140","author":"Keating","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0380","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.livres.2019.01.001","article-title":"Bile acid receptors and gastrointestinal functions","volume":"3","author":"Ticho","year":"2019","journal-title":"Liver Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.105340_bib0385","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4049\/jimmunol.1900345","article-title":"Intestinal macrophages in resolving inflammation","volume":"203","author":"Hine","year":"2019","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2020.105340_bib0390","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.cell.2015.12.023","article-title":"Neuro-immune interactions drive tissue programming in intestinal macrophages","volume":"164","author":"Gabanyi","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.phrs.2020.105340_bib0395","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0400","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.smim.2016.03.007","article-title":"The role of neutrophils in inflammation resolution","volume":"28","author":"Jones","year":"2016","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0405","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/imr.12453","article-title":"Clearance of apoptotic neutrophils and resolution of inflammation","volume":"273","author":"Greenlee-Wacker","year":"2016","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.phrs.2020.105340_bib0410","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1172\/JCI124615","article-title":"The role of macrophages in the resolution of inflammation","volume":"129","author":"Watanabe","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0415","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"18","key":"10.1016\/j.phrs.2020.105340_bib0420","doi-asserted-by":"crossref","first-page":"E6637","DOI":"10.3390\/ijms21186637","article-title":"Roles of specialized pro-resolving lipid mediators in autophagy and inflammation","volume":"21","author":"Recchiuti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.105340_bib0425","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molimm.2020.07.017","article-title":"Specialized pro-resolving mediators: it\u2019s anti-oxidant stress role in multiple disease models","volume":"126","author":"Wang","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.phrs.2020.105340_bib0430","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","article-title":"Bioactive lipids and chronic inflammation: managing the fire within","volume":"9","author":"Chiurchi\u00f9","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0435","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1568026611109060629","article-title":"Novel anti-inflammatory--pro-resolving mediators and their receptors","volume":"11","author":"Serhan","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0440","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/iep.12167","article-title":"Increased expression of phosphorylated forms of heat-shock protein-27 and p38MAPK in macrophage-rich regions of fibro-fatty atherosclerotic lesions in the rabbit","volume":"97","author":"Shafi","year":"2016","journal-title":"Int. J. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0445","doi-asserted-by":"crossref","first-page":"17894","DOI":"10.1038\/s41598-019-54502-6","article-title":"Phosphoproteomic analysis sheds light on intracellular signaling cascades triggered by Formyl-Peptide Receptor 2","volume":"9","author":"Cattaneo","year":"2019","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.phrs.2020.105340_bib0450","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.it.2018.08.005","article-title":"Formyl-peptide receptors in infection, inflammation, and cancer","volume":"39","author":"Wei\u00df","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phrs.2020.105340_bib0455","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejphar.2018.06.025","article-title":"Targeting formyl peptide receptors to facilitate the resolution of inflammation","volume":"833","author":"Filep","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.phrs.2020.105340_bib0460","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.3390\/ijms20143426","article-title":"Chemotactic ligands that activate G-Protein-Coupled formylpeptide receptors","volume":"20","author":"Krepel","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0465","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acsptsci.9b00075","article-title":"New advances in targeting the resolution of inflammation: implications for specialized pro-resolving mediator GPCR drug discovery","volume":"3","author":"Park","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"July","key":"10.1016\/j.phrs.2020.105340_bib0470","article-title":"G-protein coupled receptors involved in the resolution of inflammation: ligands and therapeutic perspectives","author":"Mastromarino","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0475","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaci.2004.09.038","article-title":"Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound","volume":"115","author":"Vachier","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phrs.2020.105340_bib0480","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mam.2017.04.003","article-title":"Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation","volume":"58","author":"Duvall","year":"2017","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.phrs.2020.105340_bib0485","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pharmthera.2018.01.004","article-title":"Towards targeting resolution pathways of airway inflammation in asthma","volume":"186","author":"Barnig","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0490","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJMoa021218","article-title":"Association of cystic fibrosis with abnormalities in fatty acid metabolism","volume":"350","author":"Freedman","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0495","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.178.1.496","article-title":"Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness","volume":"178","author":"Levy","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0500","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.alit.2014.08.003","article-title":"Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases","volume":"64","author":"Miyata","year":"2015","journal-title":"Allergol. Int."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0505","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.jaci.2015.11.045","article-title":"Airway lipoxin A4\/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma","volume":"137","author":"Gagliardo","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phrs.2020.105340_bib0510","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fimmu.2019.00047","article-title":"NETopathic inflammation in chronic obstructive pulmonary disease and severe asthma","volume":"10","author":"Uddin","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2020.105340_bib0515","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.21037\/jtd.2017.10.116","article-title":"Are specialized pro-resolving mediators promising therapeutic agents for severe bronchial asthma?","volume":"9","author":"Hisada","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.phrs.2020.105340_bib0520","first-page":"107","article-title":"Actions of lipoxin A4 and related compounds in smooth muscle preparations and on the microcirculation in vivo","volume":"229","author":"Dahl\u00e9n","year":"1988","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0525","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1165\/rcmb.2006-0172OC","article-title":"Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines","volume":"37","author":"Parameswaran","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0530","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1165\/rcmb.2005-0184OC","article-title":"Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor","volume":"34","author":"Wu","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.phrs.2020.105340_bib0535","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/178369","article-title":"AT-RvD1 modulates CCL-2 and CXCL-8 production and NF-\u03baB, STAT-6, SOCS1, and SOCS3 expression on bronchial epithelial cells stimulated with IL-4","volume":"2015","author":"de Oliveira","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.phrs.2020.105340_bib0540","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2017.03.029","article-title":"AT-RvD1 modulates the activation of bronchial epithelial cells induced by lipopolysaccharide and Dermatophagoides pteronyssinus","volume":"805","author":"de Oliveira","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0545","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbrc.2010.08.025","article-title":"Protective effect of resolvin E1 on the development of asthmatic airway inflammation","volume":"400","author":"Aoki","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0550","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/lipd.12119","article-title":"Resolvin E1 improves mitochondrial function in human alveolar epithelial cells during severe inflammation","volume":"54","author":"Mayer","year":"2019","journal-title":"Lipids"},{"issue":"8","key":"10.1016\/j.phrs.2020.105340_bib0555","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni.1627","article-title":"Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation","volume":"9","author":"Haworth","year":"2008","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2020.105340_bib0560","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4049\/jimmunol.1402534","article-title":"Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation","volume":"194","author":"Krishnamoorthy","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0565","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s10753-016-0433-0","article-title":"Maresin 1 maintains the permeability of lung epithelial cells in vitro and in vivo","volume":"39","author":"Chen","year":"2016","journal-title":"Inflammation"},{"issue":"44","key":"10.1016\/j.phrs.2020.105340_bib0570","doi-asserted-by":"crossref","first-page":"E4753","DOI":"10.1073\/pnas.1415006111","article-title":"Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection","volume":"111","author":"Dalli","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0575","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2019.09.028","article-title":"Cysteinyl maresins regulate the prophlogistic lung actions of cysteinyl leukotrienes","volume":"145","author":"Levy","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.phrs.2020.105340_bib0580","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1111\/jcmm.15146","article-title":"Maresin Conjugates in Tissue Regeneration 1 improves alveolar fluid clearance by up-regulating alveolar ENaC, Na, K-ATPase in lipopolysaccharide-induced acute lung injury","volume":"24","author":"Han","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0585","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1515\/revneuro-2017-0074","article-title":"The roles of special proresolving mediators in pain relief","volume":"29","author":"Zhang","year":"2018","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.phrs.2020.105340_bib0590","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2012.00257","article-title":"Resolution of inflammation in obesity-induced liver disease","volume":"3","author":"Rius","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2020.105340_bib0595","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3389\/fphar.2019.01022","article-title":"N-3 polyunsaturated fatty acids and the resolution of neuroinflammation","volume":"10","author":"Joffre","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0600","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1038\/s41467-019-11928-w","article-title":"Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson\u2019s disease","volume":"10","author":"Krashia","year":"2019","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.phrs.2020.105340_bib0605","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.3390\/ijms21165783","article-title":"Alzheimer\u2019s disease and specialized pro-resolving lipid mediators: Do MaR1, RvD1, and NPD1 show promise for prevention and treatment?","volume":"21","author":"Miyazawa","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.105340_bib0610","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3267172","article-title":"Resolution of inflammation in neurodegenerative diseases: the role of resolvins","volume":"2020","author":"Chamani","year":"2020","journal-title":"Mediators Inflamm."},{"issue":"9","key":"10.1016\/j.phrs.2020.105340_bib0615","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1073\/pnas.86.9.3438","article-title":"Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor","volume":"86","author":"Badr","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.phrs.2020.105340_bib0620","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation","volume":"282","author":"Sun","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.phrs.2020.105340_bib0625","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M002863200","article-title":"Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase\/leukotriene B4 12-hydroxydehydrogenase in inflammation","volume":"275","author":"Clish","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2020.105340_bib0630","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.bmcl.2008.01.013","article-title":"Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties","volume":"18","author":"Petasis","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"14","key":"10.1016\/j.phrs.2020.105340_bib0635","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1096\/fj.07-8653com","article-title":"Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism","volume":"21","author":"Levy","year":"2007","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.phrs.2020.105340_bib0640","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/aps.2011.4","article-title":"Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury","volume":"32","author":"He","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"issue":"7","key":"10.1016\/j.phrs.2020.105340_bib0645","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.4049\/jimmunol.1400942","article-title":"Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury","volume":"193","author":"Tang","year":"2014","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0650","first-page":"3083","article-title":"BML-111 suppresses TGF-\u03b21-induced lung \ufb01broblast activation in vitro and decreases experimental pulmonary fibrosis in vivo","volume":"42","author":"Ji","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0655","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12931-018-0937-2","article-title":"Lipoxin A4 receptor agonist BML-111 induces autophagy in alveolar macrophages and protects from acute lung injury by activating MAPK signaling","volume":"19","author":"Liu","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2020.105340_bib0660","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.prostaglandins.2018.08.001","article-title":"The anti-inflammatory effect of BML-111 on COPD may be mediated by regulating NLRP3 inflammasome activation and ROS production","volume":"138","author":"Cao","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"4","key":"10.1016\/j.phrs.2020.105340_bib0665","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis","volume":"177","author":"Ho","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.phrs.2020.105340_bib0670","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1096\/fj.201500155R","article-title":"Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling","volume":"30","author":"Elajami","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2020.105340_bib0675","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.plefa.2017.08.007","article-title":"Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease","volume":"125","author":"Bazan","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"3","key":"10.1016\/j.phrs.2020.105340_bib0680","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/14779072.2019.1563483","article-title":"Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases","volume":"17","author":"Satish","year":"2019","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2020.105340_bib0685","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1096\/fj.08-112201","article-title":"Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators","volume":"22","author":"Merched","year":"2008","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.phrs.2020.105340_bib0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113480","article-title":"The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells","volume":"9","author":"Chatterjee","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2020.105340_bib0695","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/ATVBAHA.115.305324","article-title":"Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis","volume":"35","author":"Hasturk","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"16","key":"10.1016\/j.phrs.2020.105340_bib0700","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.117.032801","article-title":"ERV1\/ChemR23 signaling protects against atherosclerosis by modifying oxidized low-density lipoprotein uptake and phagocytosis in macrophages","volume":"138","author":"Laguna-Fernandez","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.phrs.2020.105340_bib0705","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/cvr\/cvy316","article-title":"The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification","volume":"115","author":"Carracedo","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2020.105340_bib0710","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jss.2018.07.049","article-title":"Proresolving lipid mediators resolvin D1 and protectin D1 isomer attenuate Neointimal Hyperplasia in the rat carotid artery balloon injury model","volume":"233","author":"Makino","year":"2019","journal-title":"J. Surg. Res."},{"issue":"6S","key":"10.1016\/j.phrs.2020.105340_bib0715","doi-asserted-by":"crossref","first-page":"93S","DOI":"10.1016\/j.jvs.2018.05.253","article-title":"Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model","volume":"68","author":"Spinosa","year":"2018","journal-title":"J. Vasc. Surg."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0720","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jacbts.2018.08.005","article-title":"Resolution of inflammation through the lipoxin and ALX\/FPR2 receptor pathway protects against abdominal aortic aneurysms","volume":"3","author":"Petri","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.phrs.2020.105340_bib0725","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijcard.2014.11.010","article-title":"Aspirin-triggered 15-epi-lipoxin A\u2084 signals through FPR2\/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation","volume":"179","author":"Petri","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"June","key":"10.1016\/j.phrs.2020.105340_bib0730","article-title":"BML-111 treatment prevents cardiac apoptosis and oxidative stress in a mouse model of autoimmune myocarditis","author":"Ja\u00e9n","year":"2020","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.phrs.2020.105340_bib0735","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ecco-jcc\/jjw076","article-title":"Fibrotic and vascular remodelling of colonic wall in patients with active ulcerative colitis","volume":"10","author":"Ippolito","year":"2016","journal-title":"J. Crohns Colitis"},{"issue":"31","key":"10.1016\/j.phrs.2020.105340_bib0740","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.3748\/wjg.v25.i31.4414","article-title":"Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: prevalence, diagnosis and treatment","volume":"25","author":"Barros","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0745","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/gutjnl-2018-318081","article-title":"Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Assessment of Crohn\u2019s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review","volume":"68","author":"Bettenworth","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0750","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","article-title":"Immunopathology of inflammatory bowel disease","volume":"20","author":"Wallace","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.phrs.2020.105340_bib0755","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1053\/j.gastro.2015.07.003","article-title":"Biomarkers of inflammation in inflammatory bowel disease","volume":"149","author":"Sands","year":"2015","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.phrs.2020.105340_bib0760","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2020.105340_bib0765","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.gastro.2017.05.056","article-title":"Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing","volume":"153","author":"Chang","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2020.105340_bib0770","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12944-015-0165-4","article-title":"Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids","volume":"15","author":"Das","year":"2016","journal-title":"Lipids Health Dis."},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0775","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5152\/tjg.2020.19751","article-title":"Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome","volume":"31","author":"Karatay","year":"2020","journal-title":"Turk. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105340_bib0780","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ibd.21029","article-title":"Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis","volume":"16","author":"Ishida","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.phrs.2020.105340_bib0785","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.4049\/jimmunol.1101305","article-title":"Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice","volume":"187","author":"Bento","year":"2011","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.phrs.2020.105340_bib0790","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.4049\/jimmunol.1202743","article-title":"Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis","volume":"191","author":"Marcon","year":"2013","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2020.105340_bib0795","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.tips.2015.07.007","article-title":"Resolution pharmacology: opportunities for therapeutic innovation in inflammation","volume":"36","author":"Perretti","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0800","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbamcr.2018.11.015","article-title":"Biased perspectives on formyl peptide receptors","volume":"1866","author":"Raabe","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.105340_bib0805","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/mol.115.099630","article-title":"Fulfilling the promise of \u201cBiased\u201d g protein-coupled receptor agonism","volume":"88","author":"Luttrell","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0810","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bmcl.2015.12.024","article-title":"Biased agonism: an emerging paradigm in GPCR drug discovery","volume":"26","author":"Rankovic","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.phrs.2020.105340_bib0815","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","article-title":"Mechanisms of signaling and biased agonism in G protein-coupled receptors","volume":"19","author":"Wootten","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2020.105340_bib0820","doi-asserted-by":"crossref","first-page":"14232","DOI":"10.1038\/ncomms14232","article-title":"Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice","volume":"8","author":"Qin","year":"2017","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2020.105340_bib0825","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacbts.2019.07.005","article-title":"Preservation of post-infarction cardiac structure and function via long-term oral formyl peptide receptor agonist treatment","volume":"4","author":"Garc\u00eda","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2020.105340_bib0830","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1096\/fj.201903206R","article-title":"Dual modulation of formyl peptide receptor 2 by aspirin-triggered lipoxin contributes to its anti-inflammatory activity","volume":"34","author":"Ge","year":"2020","journal-title":"FASEB J."},{"issue":"June (9)","key":"10.1016\/j.phrs.2020.105340_bib0835","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1172\/JCI123700","article-title":"Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model","volume":"129","author":"Meriwether","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.phrs.2020.105340_bib0840","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s11596-018-1975-1","article-title":"Annexin A1 mimetic peptide AC2-26 inhibits sepsis-induced cardiomyocyte apoptosis through LXA4\/PI3K\/AKT signaling pathway","volume":"38","author":"Zhang","year":"2018","journal-title":"Curr. Issues Pharm. Med. Sci. Pract."},{"issue":"2","key":"10.1016\/j.phrs.2020.105340_bib0845","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.chembiol.2018.10.023","article-title":"Identification of chemotype agonists for human resolvin D1 receptor DRV1 with pro-resolving functions","volume":"26","author":"Chiang","year":"2019","journal-title":"Cell Chem. Biol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820316480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820316480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:20:25Z","timestamp":1760912425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820316480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":169,"alternative-id":["S1043661820316480"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105340","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105340"}}